ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Ascletis Pharma Inc (PK)

Ascletis Pharma Inc (PK) (ASCLF)

1,35
0,00
(0,00%)
Fermé 27 Juin 10:00PM

Ascletis Pharma Inc (PK) (ASCLF) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
1,35
( - )
Prix Achat
1,04
Prix Vente
1,44
Volume échangé
-
0,00 Fourchette du Jour 0,00
1,145 Plage de 52 semaines 2,50
Cap du marché
Clôture Veille
1,35
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
US$ 2 527 085
Actions en circulation
1 061 370 845
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-22,8
Bénéfice par action (BPA)
-0,37
Chiffre d'affairess (LTM)
2,03M
Bénéfice net (LTM)
-359,88M

À propos de Ascletis Pharma Inc (PK)

Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company’s commercial products include Ritonavir tablet; and ASCLEVIR and GANOVO for use in the treatment of Hepatitis C virus. It... Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company’s commercial products include Ritonavir tablet; and ASCLEVIR and GANOVO for use in the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for treating respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, and ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma; ASC61 for advanced solid tumors; and ASC40, an oral small molecule for the treatment of acne. Further, it offers ASC30, for obesity; ASC47 for muscle-preserving weight loss treatment; and ASC39, a potent and amylin-selective oral small molecule amylin receptor agonist. Ascletis Pharma Inc. was founded in 2013 and is based in Wan Chai, Hong Kong. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Site Web
Siège social
Wan Chai, Hong Kong
Fondé
2026
Ascletis Pharma Inc (PK) est coté dans le secteur Healthcare de la OTC Markets avec le ticker ASCLF. Le dernier cours de clôture d'Ascletis Pharma (PK) était de US$1,35. Au cours de la dernière année, les actions de Ascletis Pharma (PK) ont été négociées dans une fourchette de prix de US$ 1,145 à US$ 2,50.

Ascletis Pharma (PK) compte actuellement 1 061 370 845 actions en circulation. La capitalisation boursière d'Ascletis Pharma (PK) est de US$1,43 milliard. Ascletis Pharma (PK) a un ratio cours/bénéfice (ratio PE) de -22.80.

ASCLF Dernières nouvelles

Aucune actualité à afficher pour le moment.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40.032.272727272731.321.351.3215001.33CS
12-0.87-39.18918918922.222.51.3221221.99978028CS
26-0.135-9.090909090911.4852.51.3227611.8757746CS
520.0957.569721115541.2552.51.14525581.69803644CS
1561.1121467.4653215640.23792.50.140233820.9718863CS
2600.2118.42105263161.142.50.002131730.83897106CS

ASCLF - Frequently Asked Questions (FAQ)

What is the current Ascletis Pharma Inc (PK) share price?
The current share price of Ascletis Pharma Inc (PK) is US$ 1,35
How many Ascletis Pharma Inc (PK) shares are in issue?
Ascletis Pharma Inc (PK) has 1 061 370 845 shares in issue
What is the market cap of Ascletis Pharma Inc (PK)?
The market capitalisation of Ascletis Pharma Inc (PK) is USD 1,43B
What is the 1 year trading range for Ascletis Pharma Inc (PK) share price?
Ascletis Pharma Inc (PK) has traded in the range of US$ 1,145 to US$ 2,50 during the past year
What is the PE ratio of Ascletis Pharma Inc (PK)?
The price to earnings ratio of Ascletis Pharma Inc (PK) is -22,8
What is the cash to sales ratio of Ascletis Pharma Inc (PK)?
The cash to sales ratio of Ascletis Pharma Inc (PK) is 4,41k
What is the registered address of Ascletis Pharma Inc (PK)?
The registered address for Ascletis Pharma Inc (PK) is Dah Sing Financial Centre, Wan Chai
What is the Ascletis Pharma Inc (PK) website address?
The website address for Ascletis Pharma Inc (PK) is www.ascletis.com
Which industry sector does Ascletis Pharma Inc (PK) operate in?
Ascletis Pharma Inc (PK) operates in the Biotechnology & Life Sciences sector

ASCLF Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock